HIV prevention drug should be fully supported

November 19, 2014 4:49 AM

11 0

In the ongoing battle against HIV, the media still labels the drug Truvada as controversial. Approved by the Food and Drug Administration in 2012 for pre-exposure prophylaxis, or PrEP, against HIV infection, the pill has been shown to work effectively, but some continue to stir up unnecessary and dangerous skepticism about the drug.

The main culprit is Michael Weinstein, the president of the Los Angeles-based AIDS Healthcare Foundation. Starting this week, according to the The New York Times, Weinstein’s foundation will be putting out negative advertisements in gay-oriented newspapers around the nation. The ads are headlined, “...

Read more

To category page